Monday, December 2, 2013
B cells can provide a potential treatment of RNA has changed a bit.
California College San Diego medical Moores Comprehensive Cancer Center (home) of researchers successfully different kinds of white blood cells, and designed to provide a bit of a non-coding RNA or microRNA (miRNA)-it plays a central role in the immune response of the body – is targeting the T lymphocytes. Achieved in the mouse study published in this week National Science Academy Journal online early Edition are probably used for genetic recombination miRNA therapeutic purposes, the first step of the prominent vaccine and cancer treatment.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment